Ruka Setoguchi

4.5k total citations · 3 hit papers
14 papers, 3.6k citations indexed

About

Ruka Setoguchi is a scholar working on Immunology, Genetics and Molecular Biology. According to data from OpenAlex, Ruka Setoguchi has authored 14 papers receiving a total of 3.6k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Immunology, 3 papers in Genetics and 2 papers in Molecular Biology. Recurrent topics in Ruka Setoguchi's work include Immune Cell Function and Interaction (13 papers), T-cell and B-cell Immunology (11 papers) and Immunotherapy and Immune Responses (6 papers). Ruka Setoguchi is often cited by papers focused on Immune Cell Function and Interaction (13 papers), T-cell and B-cell Immunology (11 papers) and Immunotherapy and Immune Responses (6 papers). Ruka Setoguchi collaborates with scholars based in Japan, United States and Germany. Ruka Setoguchi's co-authors include Shohei Hori, Shimon Sakaguchi, Takeshi Takahashi, Haruhiko Yagi, Takashi Nomura, Masahiro Ono, Jun Shimizu, Zoltán Fehérvári, Takahisa Miyao and Hervé Luche and has published in prestigious journals such as Science, Nature Communications and The Journal of Experimental Medicine.

In The Last Decade

Ruka Setoguchi

14 papers receiving 3.5k citations

Hit Papers

Foxp3+CD25+CD4+ natural regulatory T cells in dominant se... 2005 2026 2012 2019 2006 2005 2012 400 800 1.2k

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ruka Setoguchi Japan 11 3.0k 541 428 347 183 14 3.6k
Amala Alag United States 12 3.0k 1.0× 688 1.3× 402 0.9× 238 0.7× 220 1.2× 13 3.6k
Stanley Adoro United States 12 3.3k 1.1× 793 1.5× 525 1.2× 281 0.8× 286 1.6× 20 4.1k
Terry I. Guinter United States 19 3.8k 1.3× 953 1.8× 525 1.2× 290 0.8× 249 1.4× 24 4.5k
Karsten Kretschmer Germany 28 3.4k 1.1× 545 1.0× 764 1.8× 494 1.4× 193 1.1× 52 4.2k
Yuhshi Kuniyasu Japan 7 3.4k 1.1× 570 1.1× 219 0.5× 322 0.9× 150 0.8× 8 3.8k
Benedict Seddon United Kingdom 32 3.6k 1.2× 724 1.3× 678 1.6× 337 1.0× 177 1.0× 75 4.4k
Gretta L. Stritesky United States 15 2.1k 0.7× 588 1.1× 343 0.8× 191 0.6× 142 0.8× 22 2.6k
Richard J. DiPaolo United States 30 2.6k 0.9× 635 1.2× 611 1.4× 281 0.8× 249 1.4× 66 3.6k
Renu Jain United States 22 2.0k 0.7× 445 0.8× 604 1.4× 404 1.2× 255 1.4× 33 3.0k
Bhanu P. Pappu United States 13 3.1k 1.0× 633 1.2× 683 1.6× 273 0.8× 220 1.2× 14 3.8k

Countries citing papers authored by Ruka Setoguchi

Since Specialization
Citations

This map shows the geographic impact of Ruka Setoguchi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ruka Setoguchi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ruka Setoguchi more than expected).

Fields of papers citing papers by Ruka Setoguchi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ruka Setoguchi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ruka Setoguchi. The network helps show where Ruka Setoguchi may publish in the future.

Co-authorship network of co-authors of Ruka Setoguchi

This figure shows the co-authorship network connecting the top 25 collaborators of Ruka Setoguchi. A scholar is included among the top collaborators of Ruka Setoguchi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ruka Setoguchi. Ruka Setoguchi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Setoguchi, Ruka, et al.. (2024). Memory CD8 T cells are vulnerable to chronic IFN-γ signals but not to CD4 T cell deficiency in MHCII-deficient mice. Nature Communications. 15(1). 4418–4418. 3 indexed citations
2.
Hayatsu, Norihito, Takahisa Miyao, Masashi Tachibana, et al.. (2017). Analyses of a Mutant Foxp3 Allele Reveal BATF as a Critical Transcription Factor in the Differentiation and Accumulation of Tissue Regulatory T Cells. Immunity. 47(2). 268–283.e9. 111 indexed citations
3.
Setoguchi, Ruka. (2016). IL-15 boosts the function and migration of human terminally differentiated CD8+ T cells by inducing a unique gene signature. International Immunology. 28(6). 293–305. 15 indexed citations
4.
Setoguchi, Ruka, et al.. (2014). mTOR signaling promotes a robust and continuous production of IFN‐γ by human memory CD8+ T cells and their proliferation. European Journal of Immunology. 45(3). 893–902. 14 indexed citations
5.
Miyao, Takahisa, Stefan Floess, Ruka Setoguchi, et al.. (2012). Plasticity of Foxp3+ T Cells Reflects Promiscuous Foxp3 Expression in Conventional T Cells but Not Reprogramming of Regulatory T Cells. Immunity. 36(2). 262–275. 468 indexed citations breakdown →
6.
Setoguchi, Ruka, Ichiro Taniuchi, & Michael J. Bevan. (2009). ThPOK Derepression Is Required for Robust CD8 T cell Responses to Viral Infection. The Journal of Immunology. 183(7). 4467–4474. 23 indexed citations
7.
Setoguchi, Ruka, Masashi Tachibana, Yoshinori Naoe, et al.. (2008). Repression of the Transcription Factor Th-POK by Runx Complexes in Cytotoxic T Cell Development. Science. 319(5864). 822–825. 182 indexed citations
8.
Naoe, Yoshinori, Ruka Setoguchi, Kaori Akiyama, et al.. (2007). Repression of interleukin-4 in T helper type 1 cells by Runx/Cbfβ binding to the Il4 silencer. The Journal of Experimental Medicine. 204(8). 1749–1755. 202 indexed citations
9.
Sakaguchi, Shimon, Ruka Setoguchi, Haruhiko Yagi, & Takashi Nomura. (2006). Naturally Arising Foxp3-Expressing CD25+CD4+ Regulatory T Cells in Self-Tolerance and Autoimmune Disease. Current topics in microbiology and immunology. 305. 51–66. 112 indexed citations
10.
Sakaguchi, Shimon, Masahiro Ono, Ruka Setoguchi, et al.. (2006). Foxp3+CD25+CD4+ natural regulatory T cells in dominant self‐tolerance and autoimmune disease. Immunological Reviews. 212(1). 8–27. 1270 indexed citations breakdown →
11.
Setoguchi, Ruka, Shohei Hori, Takeshi Takahashi, & Shimon Sakaguchi. (2005). Homeostatic maintenance of natural Foxp3 + CD25+ CD4+ regulatory T cells by interleukin (IL)-2 and induction of autoimmune disease by IL-2 neutralization. The Journal of Experimental Medicine. 201(5). 723–735. 992 indexed citations breakdown →
12.
Nishimura, Eiji, Toshiko Sakihama, Ruka Setoguchi, Kōichi Tanaka, & Shimon Sakaguchi. (2004). Induction of antigen-specific immunologic tolerance by in vivo and in vitro antigen-specific expansion of naturally arising Foxp3+CD25+CD4+ regulatory T cells. International Immunology. 16(8). 1189–1201. 187 indexed citations
13.
Setoguchi, Ruka, Natsumi Takeyama, Keiichi Saeki, et al.. (2004). Effects of Tacrolimus (FK506) on Encephalomyocarditic Virus‐Induced Diabetes in Mice. Microbiology and Immunology. 48(1). 7–13. 2 indexed citations
14.
Sakudo, Akikazu, Ruka Setoguchi, Keiichi Saeki, et al.. (2003). Suppressor mechanism of serum thymic factor on tumor necrosis factor-α-induced apoptosis in the mouse pancreatic β-cell line. Biochemical and Biophysical Research Communications. 311(2). 501–505. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026